Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eledon Pharmaceuticals Inc (NQ: ELDN )

3.110 +0.030 (+0.98%)
Streaming Delayed Price Updated: 10:43 AM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 886
Open 3.120
Bid (Size) 3.110 (1)
Ask (Size) 3.220 (6)
Prev. Close 3.080
Today's Range 3.110 - 3.149
52wk Range 2.030 - 4.332
Shares Outstanding 13,756,788
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Eledon Pharmaceuticals Provides Business and Pipeline Updates
From Eledon Pharmaceuticals, Inc.
Via Globe NewsWire
eGenesis and Eledon Pharmaceuticals Announce Collaboration for Use of Tegoprubart in Preclinical Xenotransplantation Studies
From eGenesis
Via Globe NewsWire

Performance

YTD
+37.01%
+37.01%
1 Month
+37.01%
+37.01%
3 Month
+32.34%
+32.34%
6 Month
+3.67%
+3.67%
1 Year
-20.46%
-20.46%

More News

Read More
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
C-Path's Transplant Therapeutics Consortium Receives EMA Qualification Opinion for iBox Scoring System
From Eledon Pharmaceuticals, Inc.
Via Globe NewsWire
Eledon Pharma: Q2 Earnings Insights
Via Benzinga
Eledon Pharmaceuticals Reports Third Quarter 2022 Operating and Financial Results
From Eledon Pharmaceuticals, Inc.
Via Globe NewsWire
Eledon Pharmaceuticals to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022
From Eledon Pharmaceuticals, Inc.
Via Globe NewsWire
Eledon Pharmaceuticals Announces Upcoming Presentations at ASN’s Kidney Week 2022 and NEALS
From Eledon Pharmaceuticals, Inc.
Via Globe NewsWire
Eledon Pharmaceuticals to Participate in Two Upcoming Conferences
From Eledon Pharmaceuticals, Inc.
Via Globe NewsWire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Eledon Shares Climb After Securing FDA Nod For Mid-Stage Kidney Disease Study
Via Benzinga
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints New Board Member
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Appoints New Board Member
Via CannabisNewsWire
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Eledon Pharmaceuticals Earnings: A Preview
Via Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Daily Biotech Pulse: Celyad Resumes Colorectal Cancer Trial, Setback For Otonomy, AstraZeneca Halts Phase 3 Head, Neck Cancer Trial
Via Benzinga
Eledon Secures FDA Clearance For Kidney Transplant Rejection Study
Via Benzinga
Recap of Monday's Biotech Catalysts - End of the Day Summary
Via Benzinga
Eledon Pharmaceuticals' Stock Gains As FDA Grants Orphan Drug Designation
Via Benzinga
The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Eledon Pharma: Q1 Earnings Insights
Via Benzinga
Earnings Outlook For Eledon Pharmaceuticals
Via Benzinga
88 Biggest Movers From Yesterday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.